Johnson & Johnson shares dipped slightly today, even as first-quarter earnings came in ahead of the consensus forecast. Shares of JNJ fell 1% to $145.16 apiece by mid-day trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell slightly. The New Brunswick, New Jersey-based medtech giant […]
Wall Street Beat
Outset Medical stock soars on optimistic analyst outlook
Outset Medical shares are on the rise after BTIG analysts initiated coverage with a “Buy” rating for the home hemodialysis company. Shares of OM rose by more than 25% to $2.58 apiece in late-afternoon trading today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The optimistic outlook […]
Johnson & Johnson to acquire Shockwave Medical for $13.1B
Johnson & Johnson announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion. Media reports previously linked Johnson & Johnson with interest in buying the intravascular lithotripsy (IVL) technology maker last year. Suggestions of interest in a deal resurfaced just weeks ago and now the companies have reached an agreement. Under […]
FTC wants more info on Boston Scientific, Axonics deal with closing timeline pushed back
Boston Scientific said today that the FTC requested additional information regarding its planned $3.7 billion acquisition of Axonics (Nasdaq:AXNX). In an SEC filing, Boston Scientific said both it and Axonics received requests from the FTC (U.S. Federal Trade Commission). The agency seeks to gather more information in connection with its review of the merger. Reports […]
Integra LifeSciences completes acquisition of J&J’s Acclarent
Integra LifeSciences announced that it completed its previously announced acquisition of Acclarent from Johnson & Johnson MedTech . Princeton, New Jersey-based Integra struck a deal with J&J to acquire Acclarent for $275 million upfront at the end of 2023. The deal also includes an additional $5 million upon the achievement of regulatory milestones. Acclarent, part […]
Haemonetics completes Attune Medical acquisition
Haemonetics announced today that it completed its previously announced acquisition of Attune Medical. Boston-based Haemonetics agreed to buy Attune for an upfront cash payment of $160 million just under a month ago. Chicago-based Attune medical develops the ensoETM proactive esophageal cooling device. The company designed ensoETM to reduce the likelihood of ablation-related esophageal injury. These […]
ZimVie closes sale of spine business, medtech veterans make up leadership team
ZimVie announced today that it completed the sale of its spine business to establish itself as a pure-play dental company. The company also shared details on the makeup of the leadership team at the now-sold business unit. The Westminster, Colorado-based ZimVie announced its intent to sell the spine business to H.I.G. Capital in December 2023. […]
3M completes Solventum healthcare business spinoff
3M announced today that it completed the spinoff of its Solventum healthcare business as a standalone company. Following the completion of the spinoff, Solventum is now listed on the New York Stock Exchange under the “SOLV” ticker. The 3M board approved the spinoff in March, confirming the effective date for today, April 1. The St. […]
Axonics stockholders approve Boston Scientific acquisition
Axonics (Nasdaq:AXNX) announced that its stockholders voted to adopt its $3.7 billion merger agreement with Boston Scientific . Boston Scientific announced its intent to buy Axonics on Jan. 8. Irvine, California-based Axonics develops neuromodulation systems for treating urinary and bowel dysfunction. Its fourth-generation R20 rechargeable sacral neuromodulation (SNM) system received FDA approval around a year ago. […]
3M board approves Solventum healthcare spinoff
3M announced last week that its board of directors approved the planned spinoff of Solventum, its Health Care business. Board approval further solidifies the company’s previously announced intent to spin Solventum into a standalone company on April 1. The St. Paul, Minnesota–based manufacturing giant first announced plans to spin off its Health Care unit in […]
Myomo has a strong outlook for 2024 with new Medicare coverage
Myomo (NYSE:MYO) shares took a hit today on fourth-quarter results that came up short of the consensus forecast. Shares of MYO fell 10% to $3.16 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 0.5%. The Boston-based wearable exoskeleton maker posted […]